Metrion Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Metrion Biosciences Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11099
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Metrion Biosciences Ltd (Metrion Biosciences) is a contract research organization that offers ion channel drug discovery services. The organization offers cardiac safety screening services, neuroscience-related assays and platforms and translational assays. Its ion channel screening services include compound screening, cell line optimization, assay development and ion channel library. Metrion Biosciences’s holds expertise from assay development, plate-based and HT screening, hit finding and lead optimisation through to preclinical outsourcing. The organization is developing a multi-electrode array (MEA) platform which is capable of making high signal:noise recordings of physiological activity from native neuronal cells such as rodent DRG neurons or brain tissue. Metrion Biosciences is headquartered in Cambridge, the UK.

Metrion Biosciences Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Metrion Biosciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors from Japan Tobacco 11
Venture Financing 12
Metrion Biosciences to Raise USD0.8 Million in Venture Financing 12
Partnerships 13
Metrion Biosciences Enters into Agreement with LifeArc 13
Metrion Biosciences Enters into Agreement with Concept Life Sciences 14
Peakdale Molecular Partners with Metrion Biosciences 15
Axiogenesis Enters into Agreement with Metrion Biosciences 16
Axol Bioscience and Metrion Biosciences Enter into Research Agreement 17
Metrion Biosciences Ltd – Key Competitors 18
Metrion Biosciences Ltd – Key Employees 19
Metrion Biosciences Ltd – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Feb 12, 2018: Metrion Biosciences Establishes Scientific Advisory Board 21
May 02, 2017: Metrion Biosciences appoints Chief Operating Officer and Head of Business Development 22
Government and Public Interest 23
Feb 05, 2018: Metrion Biosciences Awarded £200k Funding Under Innovate UK Biomedical Catalyst Feasibility Award 23
Product News 24
08/28/2018: Metrion Biosciences awarded £637k funding under Innovate UK Biomedical Catalyst Primer Award for ion channel drug discovery 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Metrion Biosciences Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Metrion Biosciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors from Japan Tobacco 11
Metrion Biosciences to Raise USD0.8 Million in Venture Financing 12
Metrion Biosciences Enters into Agreement with LifeArc 13
Metrion Biosciences Enters into Agreement with Concept Life Sciences 14
Peakdale Molecular Partners with Metrion Biosciences 15
Axiogenesis Enters into Agreement with Metrion Biosciences 16
Axol Bioscience and Metrion Biosciences Enter into Research Agreement 17
Metrion Biosciences Ltd, Key Competitors 18
Metrion Biosciences Ltd, Key Employees 19

List of Figures
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Metrion Biosciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Metrion Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Crown Resorts Ltd:戦略・SWOT・企業財務分析
    Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Accuray Inc (ARAY):製品パイプライン分析
    Summary Accuray Inc (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The company’s major produc …
  • Grant Thornton International Ltd.:戦略・SWOT・企業財務分析
    Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • WellCare Health Plans, Inc.:企業の戦略・SWOT・財務情報
    WellCare Health Plans, Inc. - Strategy, SWOT and Corporate Finance Report Summary WellCare Health Plans, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Pacgen Life Science Corp (PBS)-製薬・医療分野:企業M&A・提携分析
    Summary Pacgen Life Science Corp (Pacgen), formerly Pacgen Biopharmaceuticals Corp is a life science technology company that develops and commercializes biomedical products and services. The company offers development of novel therapeutic drug candidates. Its products include amino-acid antimicrobia …
  • Fomento de Construcciones y Contratas SA (FCC):企業の財務・戦略的SWOT分析
    Fomento de Construcciones y Contratas SA (FCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Nippon Steel & Sumitomo Metal Corp:企業の戦略・SWOT・財務情報
    Nippon Steel & Sumitomo Metal Corp - Strategy, SWOT and Corporate Finance Report Summary Nippon Steel & Sumitomo Metal Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Ausgrid:企業の戦略的SWOT分析
    Ausgrid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Entegris Inc (ENTG):企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Tidewater Inc (TDW):石油・ガス:M&Aディール及び事業提携情報
    Summary Tidewater Inc (Tidewater) is an an petroleum service company that offers offshore supply vessels and marine support services. The company's services include transport and supply of offshore material; anchor handling, towing and positioning; construction support; well stimulation, FPSO suppor …
  • CSS Industries, Inc. (CSS):企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Curetis NV (CURE)-医療機器分野:企業M&A・提携分析
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, im …
  • Ube Industries Ltd (4208):企業の財務・戦略的SWOT分析
    Ube Industries Ltd (4208) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fiesta Mart, Inc.:企業の戦略的SWOT分析
    Fiesta Mart, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Murphy Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Murphy Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Murphy Oil Corp (Murphy) is an international independent oil and gas exploration and production company. It explores for and produces crude oil, natural gas, and natural gas liquids. The company oper …
  • Golden Meditech Holdings Ltd (801):医療機器:M&Aディール及び事業提携情報
    Summary Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank serv …
  • Chiltern International Inc-製薬・医療分野:企業M&A・提携分析
    Summary Chiltern International Inc (Chiltern) is a contract research organization that provides clinical trial development services. It conducts clinical trials for medical devices, drugs, and diagnostics across all stages of development. The company offer wide range of services including clinical d …
  • PartnerRe Ltd.:企業の戦略・SWOT・財務情報
    PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report Summary PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Marks and Spencer Group plc (MKS):企業の財務・戦略的SWOT分析
    Marks and Spencer Group plc (MKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆